Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Jane Griffiths

Boehringer Ingelheim headquarters

Boehringer returns to growth in first half

German firm back on track after a tough sales period

- PMLiVE

New iPad app helps schizophrenia patients

Research shows the app ‘Wizard’ could aid memory and independence

Boehringer Ingelheim headquarters

Hikma pays $2.6bn for Boehringer’s US generics unit

Follows Teva’s $40.5bn purchase of Allgeran’s generics business earlier this week

healthcare data technology

Quarter of UK patients now diagnosing online

Survey finds people would rather self-diagnose symptoms than wait for GP appointment

- PMLiVE

AstraZeneca forms ‘smart inhaler’ digital health partnership

Follows separate deal for a health coaching app for heart attack patients

- PMLiVE

Medtronic and Samsung partner on diabetes device

Alliance will develop app to monitor glucose and insulin information

Boehringer Ingelheim headquarters

Boehringer plans new filings for Giotrif in lung cancer

Firm to file drug for squamous cell carcinoma of the lung

- PMLiVE

Boehringer’s ASCO blog picks up digital excellence award

Work by Ogilvy HealthPRwins Prescription Products/Patient Health prize

- PMLiVE

Doctor’s social network Sermo expands into Canada

Builds on the medical crowdsourcing phenomenon in health

- PMLiVE

Boehringer’s Spiriva combo approved in first EU markets

Combination therapy available countries including the UK, Ireland and Spain

Daiichi Sankyo logo

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Japanese firm’s latest product faces tough competition from a fierce NOAC market

- PMLiVE

Google unveils wearable health tracker

Builds on the tech giant’s foray into the health and wellness sector

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links